Israel Active

Tel Aviv and Hebrew University researchers have discovered an abnormal genetic process responsible for the brain disorder known as Williams Syndrome. A molecule known as a 'methyl group' disrupts healthy gene production. The findings could lead to future treatments.

A 15-year study by researchers at Jerusalem’s Shaare Zedek Medical Center showed that children suffering from Crohn’s disease and treated with nutrition had a lower chance of needing surgery in the first two years of the disease than those treated with steroids. There were many other benefits.

Two articles about the biosensors of Israel’s Neteera (see previously). They uniquely use safe, very high-frequency radar to penetrate clothing but not skin, programmed specially to monitor human vital signs. No cameras, no wearables, accurate up to 5 feet away. US FDA approved in 2022.

A detailed article about Israel’s Healables (see previously). The wearable AI device is undergoing clinical trials at Israel’s Wolfson Medical Center. Interesting background on the CEO of Healables - a Lubavitcher Chasid whose motivation was his own brain tumor and the pain after its removal.

Israel’s Novocure (see previously) announced that using its TTFields (Tumor Treating electrical Fields) technology in combination with other therapies, improved overall patient survival compared to standard therapies alone.

Israel’s Purple Biotech has two promising treatments for solid tumors in clinical (human) trials. CM24 has completed Phase 1 and is in Phase 2 for Pancreatic cancer. NT219 is in Phase 1/2 in the USA. Purple is also partnering Mor, the technology transfer subsidiary of Israel’s Clalit.

Very positive video featuring the groundbreaking cancer treatment of Israel’s New Phase (see previously). 12 patients at Israel’s Beilinson (Rabin) Medical Center in Petah Tikva are undergoing Phase 1 human safety and tolerance trials.

The new Israeli-developed Microclimate Suit is successfully eliminating congestion in heart failure patients at Israel’s Rambam hospital. It evaporates body fluids, alleviating symptoms of heart failure by reducing the level of the stress hormone BNP (B-type natriuretic peptide) by up to 50%.

Israeli doctors regularly treat eye diseases in Africa (see and previously). Sheba Medical Center has now launched a humanitarian mission to Ilorin, Nigeria to treat eye-cancer in children and improve long-term quality optical care, by establishing an intra-arterial chemotherapy center.

Nine Israeli startups have been selected for Google for Startups’ first Growth Academy program for startups in the fields of medicine and quality of life. They are Olive Diagnostics, Kai, Emble, Droxi, BoBo Balance, Agado Live, AIVF, X-Trodes, and Ritual Health Technologies.